Table 1.
Clinical characteristics of patients with cancer
| Patients with cancer |
|||
|---|---|---|---|
| All | Cachectic | Noncachectic | |
| Cancer site (n) | |||
| Lung | 8 | 4 | 4 |
| Gastric | 1 | 0 | 1 |
| Pancreatic | 1 | 1 | 0 |
| Head/Neck | 1 | 0 | 1 |
| Stage (III/IV) | 7/4 | 2/3 | 5/1 |
| Histology (n) | |||
| Adenocarcinoma | 6 | 3 | 3 |
| Squamous-cell carcinoma | 4 | 1 | 3 |
| Adenosquamous carcinoma | 1 | 1 | 0 |
| Radiotherapy (n) | 3 | 0 | 3 |
| Chemotherapy (n) | 7 | 1 | 6 |
| Platinum-based | 6 | 0 | 6 |
| Pemetrexed | 1 | 0 | 1 |
| Gemcitabine | 1 | 1 | 0 |
| ECF | 1 | 0 | 1 |
| Etoposide | 1 | 0 | 1 |
| Dexamethasone (n) | 6 | 0 | 6 |
| Weight loss (kg) | 6.9 ± 2.2 | 14.9 ± 1.2 | 0.3 ± 0.3 |
| History of smoking (n) | 9 | 4 | 5 |
| Current smokers (n) | 5 | 3 | 2 |
Data are mean ± SE. Platinum-based therapies include carboplatin (n = 3) and cisplatin (n = 3). ECF, epirubicin/cisplatin/5-fluorouracil. Doses for dexamethasone are provided in the Subjects section of the methods.